Company record
JB Chemicals and Pharmaceuticals Ltd
0 FDA warning letters since 2023 and 2 recalls in the last 12 months.
Get an email the day FDA posts anything new about JB Chemicals and Pharmaceuticals Ltd.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Jul 29 | Class I | JB Chemicals and Pharmaceuticals Ltd Drug |
Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottle, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings… Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine. |
| May 13 | Class II | JB Chemicals and Pharmaceuticals Ltd Drug |
Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai 400 030, India, Distributed by: Rising Pha… Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test |